Boardroom Alpha
Boardroom Alpha
EURK · Current Report (Form 8-K) · Filed July 6, 2026

Eureka Acquisition Corp — Current Report (Form 8-K)

Form
8-K
Filed
July 6, 2026
Period
Jun 29, 2026
Ticker
EURK
Accession
0001213900-26-075470
Boardroom Alpha · Filing insights

Shareholders approved extending the SPAC deadline to July 3, 2027, with up to 12 one-month extensions.

About Eureka Acquisition Corp
Market cap
$26M
1Y TSR
+12.6%
Sector
Industrials
CEO
Fen Zhang
Last annual meeting: Jun 29, 2026 · View full Eureka Acquisition Corp profile →

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

 

Date of Report (Date of earliest event reported): June 29, 2026

 

Eureka Acquisition Corp
(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-42152   N/A
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification Number)

 

14 Prudential Tower

Singapore 049712

(Address of principal executive offices)

 

(+1) 949 899 1827

(Registrant’s telephone number, including area code)

 

 

Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act.

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Units, consisting of one Class A ordinary share, $0.0001 par value, and one Right to acquire one-fifth of one Class A ordinary share   EURKU   The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share   EURK   The Nasdaq Stock Market LLC
Rights, each whole right to acquire one-fifth of one Class A ordinary share   EURKR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

 Item 1.01 Entry into a Material Definitive Agreement.

 

On June 30, 2026, Eureka Acquisition Corp, a Cayman Islands exempted company (the “Company”) entered into an amendment to the trust agreement dated July 2, 2024, as amended (the “Trust Amendment”), by and between the Company and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as trustee.

 

The Trust Amendment was entered in connection with the Company’s extraordinary general meeting in lieu of an annual meeting of shareholders held on June 29, 2026 (the “Extraordinary General Meeting”) to approve, among the others, the Charter Amendment Proposal (as defined below).

 

The Trust Amendment provides that, among the others, for each Monthly Extension (as defined below), the amount of $ 8,253.03 (the “Monthly Extension Fee”) shall be deposited into the trust account of the Company, and, in the event that the Monthly Extension Fee is not being deposited into the trust account by the 3rd day of each month since July 3, 2026, the Company has a period of thirty (30) days (the “Cure Period”) to pay any applicable past due payment for the Monthly Extension Fee. If the Company fails to make any applicable past due payment during the Cure Period, then the Company shall immediately cease all operations, except for the purpose of winding up, and liquidate and dissolve with the same effect as if the Company failed to complete a business combination within the prescribed timeline. A copy of the Trust Amendment is attached to this Current Report on Form 8-K as Exhibit 10.1 and is incorporated herein by reference.

 

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On June 29, 2026, the Company held the Extraordinary General Meeting. At the Extraordinary General Meeting, the shareholders of the Company approved the proposal (the “Charter Amendment Proposal”) to amend the Company’s Third Amended and Restated Memorandum and Articles of Association (the “Charter”), which provided that the Company has until July 3, 2025 to complete a business combination, and may elect to extend the period to consummate a business combination up to 12 times, each by an additional one-month extension, for a total of up to 12 months to July 3, 2026, be deleted in their entirety and the substitution in their place of the Fourth Amended and Restated Memorandum and Articles of Association (the “Amended Charter”) to provide that that the Company has until July 3, 2026 to complete a business combination, and may elect to extend the period to consummate a business combination up to 12 times, each by an additional one-month extension (the “Monthly Extensions”), for a total of up to 12 months to July 3, 2027.

 

A copy of the Amended Charter is attached to this Current Report on Form 8-K as Exhibit 3.1 and is incorporated herein by reference. The disclosures set forth in this Item 5.03 are intended to be summaries only and are qualified in their entirety by reference to the Amended Charter.

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On June 5, 2026, the record date of the Shareholder Meeting, there were 3,388,233 Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Shares”), and 1,437,500 Class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary Shares”), issued and outstanding, respectively, voting as a single class, approximately 77.7% of which were represented in person or by proxy at the Extraordinary General Meeting.

 

1

 

 

The final results for the matter submitted to a vote of the Company’s shareholders at the Extraordinary General Meeting are as follows:

 

1. The Charter Amendment Proposal

 

The shareholders approved the proposal to amend the Company’s Charter to provide that the Company has until July 3, 2026 to complete a business combination, and may elect to extend the period to consummate a business combination up to 12 times, each by an additional one-month extension, for a total of up to 12 months to July 3, 2027. The voting results were as follows:

 

FOR   AGAINST   ABSTAIN
3,135,502   611,629   0

 

2. The Auditor Appointment Proposal

 

The shareholders approved the proposal to approve the engagement of Marcum Asia CPAs LLP to serve as the Company’s independent registered public accounting firm for the year ending September 30, 2026. The voting results were as follows: 

 

FOR   AGAINST   ABSTAIN
3,195,270   551,861   0

 

Item 8.01. Other Events.

 

In connection with the votes to approve the Charter Amendment Proposal, 2,655,132 Class A Ordinary Shares of the Company were rendered for redemption. As a result, the Company has 733,101 Class A Ordinary Shares and 1,437,500 Class B Ordinary Share issued and outstanding, respectively.

 

2

 

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description of Exhibits
3.1   Fourth Amended and Restated Memorandum and Articles of Association, dated June 29, 2026.
10.1   Amendment to the Investment Management Trust Agreement dated June 30, 2026, between the Company and Continental Stock Transfer & Trust Company.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Eureka Acquisition Corp
   
  By: /s/ Fen Zhang
  Name:  Fen Zhang
  Title: Chief Executive Officer
     
Date: July 6, 2026    

 

4

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Eureka Acquisition Corp (EURK)

Reference

Frequently asked questions

When did Eureka Acquisition Corp file this 8-K?
Eureka Acquisition Corp (EURK) filed this Current Report (Form 8-K) with the SEC on July 6, 2026. The accession number assigned by EDGAR is 0001213900-26-075470.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders approved extending the SPAC deadline to July 3, 2027, with up to 12 one-month extensions. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Eureka Acquisition Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Eureka Acquisition Corp has filed under CIK 2000410, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer